Literature DB >> 17851670

[Medico-legal assessment of systemic sclerosis].

M Graninger1.   

Abstract

Diagnosis and management of the rare disease systemic sclerosis (scleroderma) is a challenge for the physician, not least due to the possible multitude of organ systems involved. The medico-legal assessment is important for the patient claiming insurance benefits or applying for early retirement due to scleroderma. Both the specialist for sclerosis and the impartial medico-legal assessor have to cooperate and understand the respective partner's requirements and terminology. Evaluations of individual organ impairments, handicaps and disabilities have to be taken into account when assessing the degree of impairment of occupational activity.

Entities:  

Mesh:

Year:  2007        PMID: 17851670     DOI: 10.1007/s00393-007-0206-0

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  23 in total

1.  Lung CT densitometry in systemic sclerosis: correlation with lung function, exercise testing, and quality of life.

Authors:  Gianna Camiciottoli; Ilaria Orlandi; Maurizio Bartolucci; Eleonora Meoni; Francesca Nacci; Stefano Diciotti; Chiara Barcaroli; Maria Letizia Conforti; Massimo Pistolesi; Marco Matucci-Cerinic; Mario Mascalchi
Journal:  Chest       Date:  2007-03       Impact factor: 9.410

2.  Validity of the Saint George's Respiratory Questionnaire in the evaluation of the health-related quality of life in patients with interstitial lung disease secondary to systemic sclerosis.

Authors:  L Beretta; A Santaniello; A Lemos; M Masciocchi; R Scorza
Journal:  Rheumatology (Oxford)       Date:  2006-07-28       Impact factor: 7.580

Review 3.  Gastrointestinal manifestations of scleroderma.

Authors:  S Rose; M A Young; J C Reynolds
Journal:  Gastroenterol Clin North Am       Date:  1998-09       Impact factor: 3.806

Review 4.  [Systemic sclerosis - diagnosis and classification].

Authors:  E Genth; T Krieg
Journal:  Z Rheumatol       Date:  2006-07       Impact factor: 1.372

5.  Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis.

Authors:  V D Steen; D L Powell; T A Medsger
Journal:  Arthritis Rheum       Date:  1988-02

6.  Silica-induced scleroderma.

Authors:  U F Haustein; V Ziegler; K Herrmann; J Mehlhorn; C Schmidt
Journal:  J Am Acad Dermatol       Date:  1990-03       Impact factor: 11.527

7.  [Occupationally-induced progressive scleroderma and the heart].

Authors:  J Mehlhorn; C Gerlach; J Vetter
Journal:  Z Gesamte Inn Med       Date:  1988-05-01

8.  Systemic sclerosis and occupational risk factors: role of solvents and cleaning products.

Authors:  Anne Maître; Martine Hours; Vincent Bonneterre; Joëlle Arnaud; Marie Tülin Arslan; Patrick Carpentier; Alain Bergeret; Régis de Gaudemaris
Journal:  J Rheumatol       Date:  2004-12       Impact factor: 4.666

9.  The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time.

Authors:  V D Steen; T A Medsger
Journal:  Arthritis Rheum       Date:  1997-11

Review 10.  Silica induced scleroderma--clinical and experimental aspects.

Authors:  U F Haustein; U Anderegg
Journal:  J Rheumatol       Date:  1998-10       Impact factor: 4.666

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.